Paramagnetic Sodium NMR Biosensors for Compartment Separation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing nuclear magnetic resonance (NMR) methods struggle to accurately separate and quantify sodium ion concentrations across different compartments in vivo, particularly in the context of cancerous tissues, due to limitations in sensitivity and specificity, and the inability to effectively differentiate between intracellular, interstitial, and blood sodium levels.
Innovation Solution
Administration of a paramagnetic cation, such as a lanthanide (III) metal ion or transition (II) metal ion complexed with an anionic macrocyclic chelate, like TmDOTP5−, to induce chemical shifts in sodium resonance frequencies, allowing for compartmental separation of sodium ions in vivo.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional 23Na-MRI methods are used to detect total sodium, then the detection covers all sodium compartments, but the ability to separate and quantify individual compartment sodium concentrations is poor
Solution Approach 1:
The patent introduces a paramagnetic shift reagent as an intermediary substance that binds to sodium ions in specific compartments (blood and interstitial spaces) to induce chemical shifts. This mediator enables the separation of overlapping NMR signals from different sodium compartments without requiring complex pulse sequences or processing methods, thus improving measurement precision while maintaining methodological simplicity.
Solution Approach 2:
The patent changes the chemical shift parameter of sodium resonance frequencies by introducing paramagnetic shift reagents. This parameter change allows the overlapping NMR signals from different sodium compartments to be spectrally resolved, enabling precise quantification of individual compartment sodium concentrations without increasing device or methodological complexity.
2Measurement precision
If invasive microelectrode techniques are used to measure interstitial sodium, then direct measurement is achieved, but tissue penetration accuracy and patient applicability deteriorate
Solution Approach 1:
The patent replaces the mechanical microelectrode insertion system with a non-invasive NMR-based detection system. By using paramagnetic shift reagents to selectively label sodium in different compartments and detecting them through NMR spectroscopy, the method achieves direct measurement accuracy without the mechanical intrusion, positioning difficulties, and patient safety concerns associated with microelectrode techniques.
3Measurement precision
If ADC or MQF methods are used to separate bound and free sodium signals, then compartmental separation is attempted, but sensitivity and specificity remain low due to signal dominance from aqueous compartments
Solution Approach 1:
The patent uses paramagnetic shift reagents as intermediaries that selectively bind to sodium ions in blood and interstitial compartments, inducing large chemical shifts that move these signals away from the intracellular sodium resonance. This intermediary approach allows the detection of signals from compartments with lower sodium concentrations despite the dominance of aqueous compartment signals, significantly improving sensitivity and specificity for compartmental separation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables precise separation and quantification of sodium ions in blood, interstitial, and intracellular compartments, providing insights into transmembrane and transendothelial gradients, which are crucial for assessing tumor aggressiveness and therapeutic efficacy.
Implementation Method 1
the paraCAn− extravasates into interstitial space of most organs but does not enter cells, only Na+e and Na+b are attracted to the paraCAn− and experience a shift in the 23Na resonance frequency
Data Source
AI summary
Paramagnetic sodium NMR biosensors and associated methods are described herein. In one embodiment, a method for detecting sodium ion irregularities in a patient can include administering a volume of metallic biosensors to a region of the patient; and detecting a volume of compartmentalized sodium ions within the region based on the administered volume of metallic biosensors, which comprises a paramagnetic cation (such as, but not limited to, a lanthanide (III) metal ion and/or a transition (II) metal ion) as the core bound to an anionic macrocyclic chelate. In some cases, the volume of compartmentalized sodium ions can further include a volume of intracellular sodium ions, a volume of interstitial sodium ions, a volume of blood sodium ions, or a combination thereof.